World's Best Scientists 2026 revealed!
Philippe Clézardin

Philippe Clézardin

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
14841
World Ranking
7133
National Ranking
231

Philippe Clézardin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Philippe Clézardin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 294 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Philippe Clézardin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Clézardin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Philippe Clézardin is affiliated with Inserm in France and has contributed extensively to research in medicine, biochemistry, genetics, and molecular biology. Their work predominantly focuses on oncology and cancer research, with specific attention to bone health and metastatic bone disease.

The primary topics of their research include:

  • Bone health and treatments
  • Management of metastatic bone disease
  • MicroRNA in disease regulation
  • Circular RNAs in diseases
  • Cancer-related molecular mechanisms research
  • Cancer diagnosis and treatment
  • Cancer cells and metastasis

Frequent coauthors collaborating with Philippe Clézardin are:

  • Martine Croset
  • Edith Bonnelye
  • Margherita Puppo
  • Cyrille B. Confavreux
  • Lamia Bouazza

Their research has been published mainly in:

  • Cancers
  • Frontiers in Oncology
  • Journal of Bone Oncology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Revue du Rhumatisme

Recent notable publications include:

  • "Bone metastasis: mechanisms, therapies, and biomarkers" (2020), Physiological Reviews
  • "Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions" (2021), Oncogene
  • "Fracture Risk Evaluation of Bone Metastases: A Burning Issue" (2021), Cancers

Other significant works relevant to their field include:

  • "Bone metastases" (2020), Nature Reviews Disease Primers
  • "The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases" (2020), Frontiers in Oncology

Philippe Clézardin's contributions reflect a broad interest in molecular biology aspects related to cancer, including the regulatory roles of microRNAs and circular RNAs in disease processes. Their research spans clinical and molecular investigations aimed at understanding the mechanisms underlying bone metastases and potential therapeutic targets.

Best Publications

  • Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.

    Sandrine Boissier;Mercedes Ferreras;Olivier Peyruchaud;Sandrine Magnetto

  • Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

    Ahmed Boucharaba;Claire-Marie Serre;Sandra Grès;Jean Sébastien Saulnier-Blache

  • Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices

    Sandrine Boissier;Sandrine Magnetto;Lucien Frappart;Béatrice Cuzin

  • SiRNA-mediated Inhibition of Vascular Endothelial Growth Factor Severely Limits Tumor Resistance to Antiangiogenic Thrombospondin-1 and Slows Tumor Vascularization and Growth

    Stéphanie Filleur;Aurélie Courtin;Slimane Ait-Si-Ali;Julien Guglielmi

  • Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone

    Isabelle Pecheur;Olivier Peyruchaud;Claire-Marie Serre;Julien Guglielmi

  • Bisphosphonates and Cancer-Induced Bone Disease: Beyond Their Antiresorptive Activity

    Philippe Clézardin;Frank H. Ebetino;Pierrick G.J. Fournier

  • The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

    Ahmed Boucharaba;Claire-Marie Serre;Julien Guglielmi;Jean-Claude Bordet

  • Bone metastasis: mechanisms, therapies, and biomarkers.

    Philippe Clézardin;Philippe Clézardin;Rob Coleman;Margherita Puppo;Penelope Ottewell

  • Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases

    Yingshe Zhao;Richard Bachelier;Isabelle Treilleux;Philippe Pujuguet

  • Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.

    Olivier Peyruchaud;Bent Winding;Isabelle Pécheur;Claire-Marie Serre

  • Bisphosphonates in cancer therapy.

    Verena Stresing;Florence Daubiné;Florence Daubiné;Ismahène Benzaid;Ismahène Benzaid;Hannu Mönkkönen;Hannu Mönkkönen

  • Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer

    Jeroen T. Buijs;Nico V. Henriquez;Petra G.M. van Overveld;Geertje van der Horst

  • A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden

    Céline Le Gall;Akeila Bellahcène;Edith Bonnelye;Jürg A. Gasser

  • Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature

    Michael Gnant;Philippe Clézardin

  • Effects of Bone-Targeted Agents on Cancer Progression and Mortality

    Robert Coleman;Michael Gnant;Gareth Morgan;Philippe Clezardin

  • Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.

    Daniele Santini;Gaia Schiavon;Gaia Schiavon;Bruno Vincenzi;Laura Maria Gaeta

  • Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug class

    Philippe Clézardin

  • Increased Dickkopf-1 expression in breast cancer bone metastases

    Nathalie Voorzanger-Rousselot;Delphine Goehrig;Delphine Goehrig;Fabrice Journé;Valérie Doriath

  • The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth

    Floriane Pez;Frédéric Dayan;Jérome Durivault;Bastien Kaniewski

  • Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel

    P. Hadji;Robert E. Coleman;C. Wilson;T. J. Powles

Frequent Co-Authors

Serge Ferrari
Serge Ferrari University of Geneva
Toshio Matsumoto
Toshio Matsumoto University of Tokushima
Ego Seeman
Ego Seeman University of Melbourne
David Karasik
David Karasik Bar-Ilan University
Kenneth J. Clemetson
Kenneth J. Clemetson University of Bern
Robert E. Coleman
Robert E. Coleman University of Sheffield
Daniele Santini
Daniele Santini Università Campus Bio-Medico
Jack Lawler
Jack Lawler Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens diverse opportunities for online learning and career advancement. For students eager to move quickly into the field of nutrition, fast track nutrition degree online programs offer an accelerated route to qualification, making it easier to enter the workforce sooner.

Those looking to lead in healthcare settings may consider an online healthcare mba. This advanced degree can help you develop specialized leadership skills and increase your earning potential in healthcare management roles.

Alternative career pathways like medical coding are also in high demand. Comparing certifications such as cpc certification helps students choose the right credential for their goals, while boosting their employability.

If you're interested in the financial side of healthcare careers, reviewing medical.coder salary trends is a crucial step. Understanding earning potential can help you make informed decisions about your education and professional development in the health sciences.

Best Scientists Citing Philippe Clézardin

Trending Scientists